title: Short-distance walking speed and timed walking distance: redundant measures for clinical trials?
abstract: The velocity of a 15-meter walk and walking endurance (distance covered in 6 minutes) are considered distinct outcomes in clinical trials of stroke rehabilitation. Comfortable velocities used for each task in 24 subjects with chronic hemiparesis were not significantly different, however. Although speed and endurance did not reflect different domains of efficacy in outpatients whose usual speed was >0.5 m/s, the fastest feasible 15-meter velocity augmented these measures.
authors.affiliation: Neurologic Rehabilitation and Research Program, Department of Neurology, Geffen School of Medicine, University of California Los Angeles, CA 90095, USA. bdobkin@mednet.ucla.edu
authors.forename: Bruce H
authors.initials: BH
authors.lastname: Dobkin
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards; D006801:Humans; D008875:Middle Aged; D010291:Paresis / Q000534:rehabilitation*; D010807:Physical Endurance; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D000071939:Stroke Rehabilitation; D013997:Time Factors; D016138:Walking / Q000502:physiology*